Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: DOC stock price vs AIV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AIV's multiple
Needs AIV P/E.
Implied fair value · at DOC's multiple
Needs DOC P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Healthpeak Properties, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Apartment Investment and Management Company · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
WELLTOWER INC.
DOC vs WELL
Ventas, Inc.
DOC vs VTR
ALEXANDRIA REAL ESTATE EQUITIES, INC.
DOC vs ARE
SL GREEN REALTY CORP
DOC vs SLG
MID AMERICA APARTMENT COMMUNITIES INC.
DOC vs MAA
AVALONBAY COMMUNITIES INC
DOC vs AVB
UDR, Inc.
DOC vs UDR
CAMDEN PROPERTY TRUST
DOC vs CPT
ESSEX PROPERTY TRUST, INC.
DOC vs ESS
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe DOC's DCF range and elevated P/E are overstating downside because the earnings base is temporarily depressed, then hold or add selectively rather than chase the P/E-based implied price, because DOC's revenue growth and balance-sheet leverage are materially cleaner than AIV's but valuation still screens above the DCF range.
The headline P/E-derived implied price of $0.07 versus DOC's current price of $20.50 suggests an extreme downside, but that result is not credible in isolation given DOC's own P/E of 205.0x and the very different capital structures and earnings profiles of DOC and AIV. On more relevant operating and asset-value measures, DOC trades at 5.0x P/S and 36.4x EV/EBITDA, while AIV trades at 3.0x P/S and 7.0x EV/EBITDA, indicating DOC is richer on earnings and cash-flow proxies but not uniformly expensive across all metrics.
Supporting Metrics
